These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 10051823)
1. [Use of driptan (oxybutinin) in patients with urgent forms of urination disorders]. Loran OB; Pushkar' DIu; Tevlin KP Urol Nefrol (Mosk); 1998; (6):24-6. PubMed ID: 10051823 [TBL] [Abstract][Full Text] [Related]
2. The urodynamic and subjective results of treatment of detrusor instability with oxybutynin chloride. Bary PR; Moisey CU; Stephenson TP; Brendler CB Prog Clin Biol Res; 1981; 78():313-9. PubMed ID: 7038709 [No Abstract] [Full Text] [Related]
3. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder. Goldenberg MM Clin Ther; 1999 Apr; 21(4):634-42. PubMed ID: 10363730 [TBL] [Abstract][Full Text] [Related]
4. Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents. Kuo HC Urology; 2004 May; 63(5):868-72. PubMed ID: 15134967 [TBL] [Abstract][Full Text] [Related]
5. [Oxybutinin-desmopressin association in the treatment of primary nocturnal enuresis with diurnal urination disorders]. De Grazia E; Cimador M Minerva Pediatr; 1999 May; 51(5):149-52. PubMed ID: 10479880 [TBL] [Abstract][Full Text] [Related]
6. [Therapeutic effects of intrarectal administration of oxybutynin]. Radziszewski P; Borkowski A Wiad Lek; 2002; 55(11-12):691-8. PubMed ID: 12715351 [TBL] [Abstract][Full Text] [Related]
7. Urge incontinence in elderly people: factors predicting the severity of urine loss before and after pharmacological treatment. Griffiths DJ; McCracken PN; Harrison GM; Moore KN Neurourol Urodyn; 1996; 15(1):53-7. PubMed ID: 8696356 [TBL] [Abstract][Full Text] [Related]
8. Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele. Almodhen F; Capolicchio JP; Jednak R; El Sherbiny M J Urol; 2007 Oct; 178(4 Pt 1):1479-82. PubMed ID: 17706702 [TBL] [Abstract][Full Text] [Related]
9. [The usefulness of micturition flow acceleration in the diagnosis of bladder instability]. Salinas Casado J; Prieto Chaparro L; Martín Garcia C; Rapariz González M; Virseda Chamorro M; Nacarino Corbacho L; Resel Estévez L Arch Esp Urol; 1993 Dec; 46(10):891-5. PubMed ID: 7511367 [TBL] [Abstract][Full Text] [Related]
10. [Combined treatment of patients with detrusor instability]. Al-Shukri SKh; Kuz'min IV; Amdiĭ RE Urologiia; 2001; (5):26-9. PubMed ID: 11641975 [No Abstract] [Full Text] [Related]
11. Detrol LA and Diropan XL for overactive bladder. Med Lett Drugs Ther; 2001 Apr; 43(1101):28. PubMed ID: 11283473 [No Abstract] [Full Text] [Related]
13. [Experience in the use of propiverine hydrochloride (P-4) for patients suffering from urinary frequency and/or incontinence]. Yokoyama O; Miyazaki K; Ishida T; Fujita Y; Hisazumi H Hinyokika Kiyo; 1990 Apr; 36(4):517-23. PubMed ID: 2378310 [TBL] [Abstract][Full Text] [Related]
19. The effect of oxybutynin treatment on cognition in children with diurnal incontinence. Sommer BR; O'Hara R; Askari N; Kraemer HC; Kennedy WA J Urol; 2005 Jun; 173(6):2125-7. PubMed ID: 15879864 [TBL] [Abstract][Full Text] [Related]
20. [Cutaneous administration rather than swallowing]. Schubert-Zsilavecz M Krankenpfl J; 2005; 43(7-10):186. PubMed ID: 16515258 [No Abstract] [Full Text] [Related] [Next] [New Search]